TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 3:59 PM
10.73
-2.19%
After-hours: Aug 15, 2025, 05:33 PM EDT
TransCode Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.05 | -0.99 | -14.17 | -6.39 | -5.24 | -1.4 | -67.13 | -104.49 | -169.19 | -2.3 | -538.09 | -570.4 | -1.75K | -17.85 | -2.42K | 1.74K | -2.28K |
PEG Ratio | -0.00 | 0.00 | 0.09 | -0.46 | 0.05 | -0.00 | 1.02 | 2.32 | 1.70 | -0.00 | 65.66 | -17.11 | 17.66 | -0.00 | 13.00 | -10.73 | 25.05 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 30.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.23 | -11.66 | 79.60 | 100.27 | 15.22 | 13.96 | 320.52 | 867.19 | -13.75K | 52.30 | 1.12K | 850.94 | 1.42K | 30.92 | 962.69 | -8.13K | -5.21K |
P/FCF Ratio | -0.77 | -7.48 | -33.5 | -56.55 | -17.7 | -4.07 | -405.39 | -411.48 | -719.47 | -41.87 | -2.09K | -3.1K | -6.07K | -374.07 | -7.1K | -416.78K | -68.48K |
P/OCF Ratio | -0.77 | -7.48 | -33.61 | -56.66 | -17.72 | -4.04 | -405.92 | -413.18 | -721.52 | -42.16 | -2.09K | -3.14K | -6.12K | -394.1 | -7.27K | -538.74K | -78.35K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -7.52 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | -0.02 | 0.09 | 0.17 | 0.07 | 0.27 | 0.13 | 0.32 | -3.24 | n/a | n/a | n/a | n/a | n/a | n/a | -0.42 | -0.27 |
Quick Ratio | 5.20 | 2.56 | 1.58 | 1.25 | 2.48 | 1.28 | 1.67 | 1.39 | 0.80 | 1.57 | 3.02 | 8.06 | 10.08 | 8.97 | 11.43 | 0.35 | 0.73 |
Current Ratio | 5.20 | 2.56 | 1.58 | 1.25 | 2.48 | 1.28 | 1.67 | 1.39 | 0.80 | 1.70 | 3.07 | 8.06 | 10.08 | 8.97 | 11.43 | 0.35 | 0.73 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -27.82K | -2.78K | -200.61 | -1.14K | -338.86 | -72.61 | n/a | -654.19 | -364.96 | n/a | n/a | n/a | n/a | n/a | -7.09K | -8.47 | -8.52 |
Return on Equity | -1.17 | 2.93 | -1.4 | -3.93 | -0.73 | -2.49 | -1.19 | -2.07 | 20.32 | -5.68 | -0.52 | -0.37 | -0.2 | -0.43 | -0.1 | -1.17 | 0.57 |
Return on Assets | -0.92 | -0.81 | -0.59 | -1.08 | -0.46 | -0.79 | -0.52 | -0.74 | -0.86 | -2.43 | -0.36 | -0.33 | -0.18 | -0.39 | -0.09 | 3.87 | -4.32 |
Return on Invested Capital | -0.3 | -1.12 | -1.2 | -3.3 | -0.67 | -1.94 | -1.06 | -2.18 | -9.21 | -6.12 | -0.6 | -0.38 | -0.2 | -0.22 | -0.1 | 69.82 | -1.8 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.81 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -5.43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -5.43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -5.39 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -5.17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |